Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD)

Sharon M. Moe, Martina Reslerova, Markus Ketteler, Kalisha O'Neill, Danxia Duan, Jacob Koczman, Ralf Westenfeld, Willi Jahnen-Dechent, Neal X. Chen

Research output: Contribution to journalArticle

298 Scopus citations


Background. The majority of patients with chronic kidney disease (CKD) have excessive vascular calcification; however, most studies demonstrate that a subset of CKD patients do not have, nor develop, vascular calcification despite similar exposure to the uremic environment. This suggests protective mechanisms, or naturally occurring inhibitors, of calcification may be important. Methods. In order to determine the role of three inhibitors, fetuin-A, matrix gla protein (MGP), and osteoprotegerin (OPG) in the vascular calcification observed in patients with CKD-5, we (1) measured serum levels of these inhibitors and compared the levels to calcification assessed by computed tomography (CT); (2) examined arteries from CKD-5 patients by immunostaining for these inhibitors; and (3) examined the expression and effect of these inhibitors in cultured bovine vascular smooth muscle cells (BVSMCs) incubated in serum pooled from uremic patients compared to healthy controls. Results. There was a negative correlation of coronary artery calcification scores with serum fetuin-A levels (r = -0.30, P = 0.034) and a positive association with OPG levels (r = 0.29, P = 0.045). There was increasing immunostaining for both fetuin-A and MGP in arteries with increasing calcification graded semiquantitatively (P < 0.003). In vitro, fetuin-A added to mineralizing BVSMCs inhibited mineralization (P < 0.001). Compared to normal serum, BVSMCs incubated with uremic serum had a progressive increase in MGP expression with mineralization (P < 0.001) and increased expression of OPG in BVSMCs (P < 0.04). Conclusion. These data demonstrate that fetuin-A, OPG, and MGP play an important role in the pathogenesis of uremic vascular calcification.

Original languageEnglish (US)
Pages (from-to)2295-2304
Number of pages10
JournalKidney international
Issue number6
StatePublished - Jun 2005


  • CKD
  • Dialysis
  • Fetuin-A
  • Matrix gla protein
  • Osteoprotegerin
  • Vascular calcification

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD)'. Together they form a unique fingerprint.

  • Cite this